A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...

Moderna on Thursday pushed back the time frame for likely approval of a combination vaccine meant to protect against both ...

The Centers for Disease Control and Prevention will no longer recommend routine Covid shots for healthy children and pregnant ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

There is no “the” vaccine. There are at least two mRNA vaccines (Moderna and Pfizer) and a number of different non-mRNA ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against COVID-19 and most strains of flu than existing ...

Rise of the 100-somethings Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against COVID-19 and most ...

Kennedy Jr. The U.S. vaccine maker reported ... investors," he said. Moderna said on Thursday it now does not expect regulatory approval for its combination flu/COVID-19 shot until 2026, after ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...